| Views | |
|---|---|
| The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models | 222 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models | 3 | 8 | 7 | 3 | 1 | 1 | 3 |
| Views | |
|---|---|
| journal.pone.0182852.pdf | 160 |
